UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms

American journal of physiology. Regulatory, integrative and comparative physiology, 2010-03, Vol.298 (3), p.R627-R634

2010

Volltextzugriff (PDF)

A Role for Suppressed Thermogenesis Favoring Catch-Up Fat in the Pathophysiology of Catch-Up Growth

Diabetes (New York, N.Y.), 2003-05, Vol.52 (5), p.1090-1097

2003

Volltextzugriff (PDF)

CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy

Journal of clinical oncology, 2024-07, Vol.42 (20), p.2393-2403

2024

Volltextzugriff (PDF)

Mutation of the circadian clock gene per2 alters vascular endothelial function

Circulation (New York, N.Y.), 2007-04, Vol.115 (16), p.2188-2195

2007

Volltextzugriff (PDF)

Abstract 971: Validation of a tumor-naïve circulating tumor DNA (ctDNA) response monitoring panel in advanced non-small cell lung cancer (aNSCLC)

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.971-971

2024

Volltextzugriff (PDF)

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF^sup V600^ mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

European journal of cancer (1990), 2017-07, Vol.79, p.176

2017

Volltextzugriff (PDF)

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

European journal of cancer (1990), 2017-07, Vol.79, p.176-184

2017

Volltextzugriff (PDF)

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

European journal of cancer (1990), 2017-07, Vol.79, p.176-184

2017

Volltextzugriff (PDF)

Phase III randomized, open label study (ARCHER 1050) of first-line dacomitinib (D) versus gefitinib (G) for advanced (adv) non-small cell lung cancer (NSCLC) in patients (pts) with epidermal growth factor receptor ( EGFR ) activating mutation(s)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS8123-TPS8123

2013

Volltextzugriff (PDF)

Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms

American journal of physiology. Regulatory, integrative and comparative physiology, 2010, Vol.67 (3)

2010

Volltextzugriff (PDF)

ARCHER: Dacomitinib (D; PF-00299804) versus erlotinib (E) for advanced (adv) non-small cell lung cancer (NSCLC)—A randomized double-blind phase III study

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS7615-TPS7615

2012

Volltextzugriff (PDF)

Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

American Journal of Physiology: Cell Physiology, 2007-08, Vol.293 (2), p.H1265-H1272

2007

Volltextzugriff (PDF)

3Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

American journal of physiology. Heart and circulatory physiology, 2007, Vol.62 (2)

2007

Volltextzugriff (PDF)

P-322: Alterations in blood pressure and heart rate during cyclic changes in food intake

American journal of hypertension, 2002-04, Vol.15 (S3), p.147A-147A

2002

Volltextzugriff (PDF)

Alterations in blood pressure and heart rate during cyclic changes in food intake

American journal of hypertension, 2002-04, Vol.15 (4), p.A147-A147

2002

Volltextzugriff (PDF)

Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

American journal of physiology. Heart and circulatory physiology, 2007-08, Vol.293 (2), p.H1265-H1272

2007

Volltextzugriff (PDF)

Direct and indirect methods used to study arterial blood pressure

Journal of pharmacological and toxicological methods, 2000-09, Vol.44 (2), p.361-373

2000

Volltextzugriff (PDF)

Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer

Clinical investigation, 2013-01, Vol.3 (1), p.29-35

2013

Volltextzugriff (PDF)

Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits

American journal of hypertension, 2000-05, Vol.13 (5), p.556-559

2000

Volltextzugriff (PDF)

Short-term (5-day) changes in food intake alter daily hemodynamics in rabbits

American journal of hypertension, 2003-04, Vol.16 (4), p.302-306

2003

Volltextzugriff (PDF)

Multiple mechanisms involved in obesity-induced hypertension

Heart, lung & circulation, 2003, Vol.12 (2), p.84-93

2003

Volltextzugriff (PDF)

Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits

Autonomic neuroscience, 2001-07, Vol.90 (1), p.152-157

2001

Volltextzugriff (PDF)

Serial changes in cardiovascular and renal function of rabbits ingesting a high-fat, high-calorie diet

American journal of hypertension, 1999-08, Vol.12 (8), p.826-829

1999

Volltextzugriff (PDF)

Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits: Special Issue: Neural Regulation of Cardiovascular Function Explored in the Frequency Domain

Autonomic neuroscience, 2001, Vol.90 (1-2), p.152-157

2001

Volltextzugriff (PDF)

Acute lymphoblastic leukaemia in childhood: cell proliferation without rest

British journal of haematology, 1997-02, Vol.96 (2), p.366-368

1997

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(42)
Tagungsberichte
(1)

Sprache

Englisch
(43)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(15)
Male
(11)
Biological And Medical Sciences
(10)
Animals
(9)
Humans
(9)
Medical Sciences
(8)
Blood Pressure
(7)
Blood And Lymphatic Vessels
(5)
Blood Pressure - Physiology
(5)
Cardiology. Vascular System
(5)
Heart Rate - Physiology
(5)
Hypertension
(5)
Obesity
(5)
Rabbits
(5)
Telemetry
(5)
Arterial Hypertension. Arterial Hypotension
(4)
Cardiovascular System & Cardiology
(4)
Experimental Diseases
(4)
Female
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms

A Role for Suppressed Thermogenesis Favoring Catch-Up Fat in the Pathophysiology of Catch-Up Growth

CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy

Mutation of the circadian clock gene per2 alters vascular endothelial function

Abstract 971: Validation of a tumor-naïve circulating tumor DNA (ctDNA) response monitoring panel in advanced non-small cell lung cancer (aNSCLC)

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF^sup V600^ mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis

Phase III randomized, open label study (ARCHER 1050) of first-line dacomitinib (D) versus gefitinib (G) for advanced (adv) non-small cell lung cancer (NSCLC) in patients (pts) with epidermal growth factor receptor ( EGFR ) activating mutation(s)

Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms

ARCHER: Dacomitinib (D; PF-00299804) versus erlotinib (E) for advanced (adv) non-small cell lung cancer (NSCLC)—A randomized double-blind phase III study

Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

3Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

P-322: Alterations in blood pressure and heart rate during cyclic changes in food intake

Alterations in blood pressure and heart rate during cyclic changes in food intake

Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

Direct and indirect methods used to study arterial blood pressure

Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer

Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits

Short-term (5-day) changes in food intake alter daily hemodynamics in rabbits

Multiple mechanisms involved in obesity-induced hypertension

Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits

Serial changes in cardiovascular and renal function of rabbits ingesting a high-fat, high-calorie diet

Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits: Special Issue: Neural Regulation of Cardiovascular Function Explored in the Frequency Domain

Acute lymphoblastic leukaemia in childhood: cell proliferation without rest

Suchergebnisse filtern